Inspra

Eplerenone, the active ingredient in Inspra, is a selective aldosterone antagonist presented as an oral tablet for systemic use. It reduces sodium retention and potassium loss, helping to lower blood pressure and improve cardiac remodeling in patients with hypertension or heart failure following myocardial infarction.

GNH USA supplies Inspra as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality for cardiovascular therapy programs across multiple regions and patient populations.

Eplerenone is an aldosterone antagonist used in cardiovascular disease management. - Hypertension: lowers blood pressure by reducing sodium and water retention. - Heart failure (post‑myocardial infarction): improves survival and reduces hospitalizations by decreasing cardiac remodeling. - Heart failure with reduced ejection fraction: decreases morbidity by attenuating ventricular remodeling.

Eplerenone may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Hyperkalemia: elevated serum potassium levels. - Hyponatremia: low sodium concentration. - Dizziness: light‑headed sensation, especially on standing. - Headache: mild to moderate cranial pain. - Fatigue: generalized tiredness. - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Severe hyperkalemia: potentially life‑threatening cardiac arrhythmias. - Renal impairment: worsening kidney function. - Allergic reactions: rash, pruritus, or angioedema.

When prescribing eplerenone, clinicians should consider several precautionary measures to ensure safe use. - Monitor potassium: check serum potassium before initiation and periodically during therapy. - Assess renal function: evaluate creatinine clearance and adjust use in renal impairment. - Avoid in severe hyperkalemia: contraindicated when potassium >5.0 mmol/L. - Use cautiously in pregnancy: category B, weigh maternal benefits against potential fetal risks. - Review concomitant medications: consider drugs that affect potassium or renal function. - Store at ambient temperature: keep tablets below 25 °C in original packaging, protected from moisture.

Eplerenone can interact with other medicines, altering potassium balance or renal handling.

Major Interactions (Avoid): - Potassium‑sparing diuretics (e.g., spironolactone, amiloride): risk of severe hyperkalemia. - ACE inhibitors or ARBs: additive increase in serum potassium and possible renal dysfunction. - NSAIDs (e.g., ibuprofen, naproxen): may impair renal clearance and raise potassium levels.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium can affect digoxin toxicity. - Beta‑blockers: monitor blood pressure and heart rate for additive effects. - Antacids containing potassium: may contribute to hyperkalemia.